Feed / IBRX

ImmunityBio, Inc.

IBRX

Healthcare · 8.19 +8.1% today

Isolated · not yet confirmedMarket checked 25 Aug, 15:55 GMT-4

Jodie situation report

ImmunityBio, Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 37 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 7 directly disclosed connections are confirming.

Company+8.1% todayVolume comparison unavailable
Market group0 of 37 activeBiotechnology · unavailable
Disclosed network0 of 7 confirmingNo filing-linked name is confirming now
What would change this read
  • Management says continuing operating cash outflows create substantial doubt about going concern without additional funding or financial support.

Invalidation: The isolated read changes if IBRX's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind IBRX

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

MRKMerck & Company, Inc.supplierMay 7, 2026

This addresses a significant supply challenge: TICE BCG (Merck) has been the sole supplier of BCG product in the U.S.

ONCBeOne Medicines AGpartnerFeb 23, 2026

Partnership: January 2025 collaboration with BeOne.

Depended on by

URGNUroGen Pharma Ltd.competitorMar 2, 2026

We are aware of several pharmaceutical companies that are developing drugs in the general fields of urology and uro-oncology, such as AstraZeneca, Aura Biosciences., Bristol Myers Squibb, CG Oncology, enGene Holdings, Ferring Pharmaceuticals, Fidia Pharmaceut…

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 5 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

IBRX is currently a Follower in the organic co-movement group Biotechnology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.